The $0.31 question
At the end of 2024, I reordered biological indicators for our steam sterilizer. One supplier quoted $14.20 for a box of 50. Another quoted $13.89. A difference of $0.31 per indicator. I almost clicked the cheaper option and moved on. But I've been doing procurement for a 35-person surgery center for six years, and I have a folder full of times that “saved” money actually cost money. So I dug a little deeper.
The cheaper box came from a distributor that had missed deliveries twice in the past year. The slightly more expensive option was a ResiTest STERIS biological indicator with lot documentation, a 24-hour readout, and a support team that answers the phone. I calculated the real cost: if one delayed shipment forced us to hold a load, or if one undocumented lot caused a compliance headache, the savings disappeared. We bought the ResiTest STERIS indicators.
The problem isn't the price tag. It's the process.
That decision should have been simple. It wasn't, because I was initially thinking in line items. The real question isn't “which biological indicator is cheaper?” It's “what does it take to reliably release a sterilized load?”
That's the deeper issue I keep running into. Many teams comparing quotes for sterilization equipment, sterilizer consumables, or laboratory instruments treat the purchase order as the whole story. The PO is visible. It shows up on a spreadsheet. But the process around the product is where the cost lives.
What I mean is this: if you choose a biological indicator based on unit price alone, you're ignoring the process events that make that indicator valuable. A positive read. A false positive. A missed delivery. A lot number you can't trace. Those events don't appear on the original PO. They show up on a different spreadsheet—the one you don't look at until someone asks why a patient may have been exposed to a potentially unsterile instrument.
Total cost of ownership sounds like a buzzword. In practice, it's just a list of what can go wrong and who pays for it. For sterilization, that includes the sterilizer's cycle time, the biological indicator's readout time, the service technician's drive time, and the facility's tolerance for a false positive. Every one of those has a number attached.
What high-stakes sterilization really costs
The same logic applies at a much larger scale. Take a pacemaker. If you're a device manufacturer contracting out sterilization of implantable devices, you are not buying a sterilization cycle. You are buying the documented assurance that every unit in a lot is sterile. The cheapest contract sterilizer can look great in a comparison table. Then the batch release gets delayed because the dose map doesn't align with a new product geometry. Or an auditor asks for a report that takes three weeks to produce. The cost of that delay isn't in the sterilization quote.
In contract sterilization for pacemakers, the per-unit cost might be low enough to look insignificant. But the value of a single batch release is not the per-unit price. If a missed release date pushes a product launch or delays a surgical case, the sterilization vendor's “savings” disappear in one afternoon.
In lab equipment, the pattern is identical. I watched a team buy a chemistry analyzer because the upfront price and per-test cost looked outstanding. They forgot to include the water purification upgrade, the daily QC materials, calibration verification, and the service contract that starts after 90 days. The analyzer ended up costing 27% more than the alternative over five years.
If you're comparing types of laboratory incubators—water-jacketed versus forced-air, CO₂ versus non-CO₂—the same mistake happens. People compare chamber volume, temperature range, and sticker price. They don't compare temperature recovery after door openings, how often the CO₂ sensor drifts, or what a contamination event costs in lost experiments. Those are the numbers that matter.
Downtime is a price, not an accident
I've also learned to account for where equipment and service teams are actually located. In 2023, our washer-disinfector went down. The manufacturer's service quote was $3,100. The machine stayed down for four days. We rented a replacement unit for $1,650. We paid overtime to get instruments processed at another facility—another $1,200. Total out-of-pocket: $5,950. That doesn't include the canceled procedures or the phone calls to surgeons.
What made it worse is that our service contract was based on the lowest annual premium, not on response time. I should have asked which regional depot covered us and what the response radius was. One colleague in the Midwest found that the STERIS Franklin Park service center covered their region. The response time estimate was much shorter than the national call center's default window. That mattered more than the contract premium. Location is part of total cost.
The cost of the old mindset
The “buy cheap, maintain later” mindset made a certain kind of sense in 2008, when equipment was simpler and labor and regulatory risk were lower. That's changed. The hidden costs haven't gone away; they've grown.
According to ANSI/AAMI ST79, biological indicators must be used in every load containing implantable devices. That requirement isn't optional. It means the real cost of a biological indicator includes what happens after a positive result. A failed load has to be documented, reprocessed, and reviewed. If the indicator's documentation is weak, that review takes longer and costs more.
There's also ISO 11138, the standard that sets performance requirements for biological indicators. It covers the spores, the growth medium, and the packaging. Without that foundation, a biological indicator is just a tube with a mystery inside. In sterilization, a mystery is not worth the price of a cheaper box.
After our washer-disinfector failure, I audited our service and consumable spending from 2023 through mid-2024. The result was uncomfortable: 41% of the money we spent on repairs went to equipment that had been “cheaper” to buy or maintain at the outset. That's a small sample, but it changed how I make decisions.
What I do now: four buckets
I'm not a finance person. I'm a procurement manager who got burned enough times to build a simple spreadsheet. For any purchase above $5,000, I use a five-year cost model with four buckets:
- Acquisition: not just the quote, but freight, taxes, installation, room modifications, and initial validation.
- Operations: consumables, utilities, service contracts, training, calibration, and the time your staff spends managing the equipment.
- Failure risk: downtime, false positives, reprocessing, lost procedures, documentation errors, and regulatory exposure. This is the bucket most people skip.
- Exit: resale value, decommissioning cost, and how long the equipment can support your workflow before replacement.
Then I compare vendors on each bucket. Sometimes the lower-priced vendor wins. Sometimes STERIS wins. Sometimes a regional service shop wins. The point isn't the brand; it's the model.
Caveats and final thought
One caveat: my experience is based on an outpatient surgery center and a small lab. If you're running a 500-bed hospital, a high-volume central sterile processing department, or a contract sterilization facility for implantable devices, your numbers will look different. The framework transfers. The specific costs don't.
So next time you get a quote for a ResiTest STERIS biological indicator, a service plan with a regional depot like STERIS Franklin Park, a chemistry analyzer, or any type of laboratory incubator, don't ask “what's the price?” Ask “what's the process?” That's where the real price lives.
